TGA recommendation to reschedule codeine analgesics to S4 in June 2016

By Team VIVA! | October 2, 2015

The Therapeutic Goods Administration’s (TGA) Advisory Committee on Medicines Scheduling has made an interim recommendation to reschedule codeine-containing products from S3 (Pharmacist Only Medicine) to S4 (Prescription Only Medicine) from June 2016. The decision is predicated on risk dependence and the adverse effects of codeine-based products compared to newly released forms of ibuprofen and paracetamol…

Read More